Literature DB >> 15474109

The biology of intratympanic drug administration and pharmacodynamics of round window drug absorption.

Avik Banerjee1, Lorne S Parnes.   

Abstract

The application of therapeutic agents to the round window holds great promise in the treatment of inner ear disease. The primary benefit of this route of administration is the ability to achieve high inner ear concentrations of drugs without systemic side effects. Recent research has elucidated the anatomy and physiology of the round window and provided important information on the inner ear pharmacokinetics and the pharmacodynamics of drugs administered intratympanically. Although amino-glycosides and steroids have been most thoroughly studied, many other classes of pharmaceuticals, including otoprotective agents, other antibiotics,and topical anesthetics, have therapeutic potential in the inner ear and will probably be the subject of future studies. The authors believe that direct delivery approaches other than through the round window, perhaps with slow or sustained release formulations, may hold the key to the future treatment of inner ear disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15474109     DOI: 10.1016/j.otc.2004.04.003

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  10 in total

Review 1.  Clinical trials evaluating transtympanic otoprotectants for cisplatin-induced ototoxicity: what do we know so far?

Authors:  Sofia Waissbluth
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-05-01       Impact factor: 2.503

Review 2.  Issues, indications, and controversies regarding intratympanic steroid perfusion.

Authors:  Mohamed Hamid; Dennis Trune
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2008-10       Impact factor: 2.064

Review 3.  Intratympanic steroids as primary initial treatment of idiopathic sudden sensorineural hearing loss. The Hospital Universitario Ramón y Cajal experience and review of the literature.

Authors:  Tomás Labatut; María José Daza; Antonio Alonso
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-20       Impact factor: 2.503

4.  Transtympanic steroids in refractory sudden hearing loss. Personal experience.

Authors:  I Dallan; L Bruschini; A Nacci; B Fattorp; A C Traino; F Rognini; G Ferraro; P Bruschini
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-02       Impact factor: 2.124

5.  Systemic dexamethasone for the prevention of cisplatin-induced ototoxicity.

Authors:  Sofia Waissbluth; Pezhman Salehi; Xinying He; Sam J Daniel
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-21       Impact factor: 2.503

6.  Localized cell and drug delivery for auditory prostheses.

Authors:  Jeffrey L Hendricks; Jennifer A Chikar; Mark A Crumling; Yehoash Raphael; David C Martin
Journal:  Hear Res       Date:  2008-06-07       Impact factor: 3.208

Review 7.  Inner ear drug delivery for auditory applications.

Authors:  Erin E Leary Swan; Mark J Mescher; William F Sewell; Sarah L Tao; Jeffrey T Borenstein
Journal:  Adv Drug Deliv Rev       Date:  2008-09-21       Impact factor: 15.470

Review 8.  Advances in nano-based inner ear delivery systems for the treatment of sensorineural hearing loss.

Authors:  Lilun Li; Tiffany Chao; Jason Brant; Bert O'Malley; Andrew Tsourkas; Daqing Li
Journal:  Adv Drug Deliv Rev       Date:  2016-01-12       Impact factor: 15.470

9.  Permeability of the round window membrane is influenced by the composition of applied drug solutions and by common surgical procedures.

Authors:  Anthony A Mikulec; Jared J Hartsock; Alec N Salt
Journal:  Otol Neurotol       Date:  2008-10       Impact factor: 2.311

10.  Association of Sodium Thiosulfate With Risk of Ototoxic Effects From Platinum-Based Chemotherapy: A Systematic Review and Meta-analysis.

Authors:  Chih-Hao Chen; Chii-Yuan Huang; Heng-Yu Haley Lin; Mao-Che Wang; Chun-Yu Chang; Yen-Fu Cheng
Journal:  JAMA Netw Open       Date:  2021-08-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.